rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    COCH
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Envoy Medical regains Nasdaq minimum bid price compliance
      Nov 10Investing.comCOCH
      Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
      Nov 10Yahoo FinanceCOCH
      Envoy Medical Inc (COCH) (Q3 2026) Earnings Call Highlights: Acclaim Trial Fully Enrolled as ...
      Nov 6Yahoo FinanceCOCH
      Envoy Medical, Inc. Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinanceCOCH
      Envoy Medical earnings beat by $0.20, revenue topped estimates
      Nov 5Investing.comCOCH
      Envoy Medical Q3 2026 Earnings Call Transcript
      Nov 5BenzingaCOCH
      Envoy Medical, Inc. (COCH) Reports Q3 Loss, Tops Revenue Estimates
      Nov 5Yahoo FinanceCOCH
      Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress
      Nov 5Yahoo FinanceCOCH
      Earnings To Watch: Envoy Medical Inc (COCH) Q3 2026 -- GF Value Sees 30% Downside
      Nov 4Yahoo FinanceCOCH
      Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th

      Financial Results to Be Released Before Market OpenWhite Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has updated the time of its conference call to discuss financial results for the third quarter ended September 30, 2026. The conference call will now be held at 8:00 A.M. ET on Thursday, November.

      Oct 28Yahoo FinanceCOCH
      Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
      Oct 27Yahoo FinanceCOCH
      Envoy Medical announces 1-for-10 reverse stock split
      Oct 22Investing.comCOCH
      Envoy Medical Announces Reverse Stock Split
      Oct 22Yahoo FinanceCOCH
      Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
      Oct 20Yahoo FinanceCOCH
      Envoy Medical stock price target maintained at $2 by H.C. Wainwright
      Oct 13Investing.comCOCH
      Envoy Medical submits second FDA module for Acclaim implant
      Oct 12Investing.comCOCH
      Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

      Second of Four Planned Modules Moves Rolling FDA Review ForwardAdvances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced the submission of the second module of its Modular Premarket Approval ("PMA") application to the U.S. Food

      Oct 12Yahoo FinanceCOCH
      Lake Street initiates Envoy Medical stock at buy on cochlear device
      Oct 6Investing.comCOCH
      Envoy Medical receives patents in Canada and Hong Kong
      Sep 22Investing.comCOCH
      Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

      Canadian and Hong Kong Patents Continue to Strengthen Intellectual Property Protection Across Envoy Medical's Fully Implanted Hearing PlatformWhite Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the grant of two additional international patents, expanding its global intellectual property portfolio to 97 patents, consisting of

      Sep 22Yahoo FinanceCOCH
      Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

      White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, on September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.H.C. Wainwright Conference Presentation...

      Sep 2Yahoo FinanceCOCH

      This is the newest page. Registered accounts read further back.